Bristol-Myers Squibb CompanyBMYNYSE
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+7.2%
5Y CAGR+8.5%
Year-over-Year Change
Revenue minus cost of goods sold
3Y CAGR
+7.2%/yr
vs +13.3%/yr prior
5Y CAGR
+8.5%/yr
Consistent
Acceleration
-6.1pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $32.60B | +18.8% |
| 2024 | $27.43B | +8.2% |
| 2023 | $25.36B | -4.3% |
| 2022 | $26.49B | -1.0% |
| 2021 | $26.76B | +23.3% |
| 2020 | $21.70B | +25.8% |
| 2019 | $17.25B | +7.3% |
| 2018 | $16.07B | +7.5% |
| 2017 | $14.96B | +3.2% |
| 2016 | $14.49B | - |